EMA Recommends Extending Indications for Decitabine / Cedazuridine By Ogkologos - May 29, 2026 97 0 Facebook Twitter Google+ Pinterest WhatsApp New indication concerns a combination with venetoclax for the treatment of adult patients with newly diagnosed AML Source RELATED ARTICLESMORE FROM AUTHOR Mezigdomide-Carfilzomib-Dexamethasone Prolongs PFS Compared with Carfilzomib-Dexamethasone at First Relapse in Patients with Relapsed Or Refractory Multiple Myeloma FDA Approves Durvalumab in Combination with BCG for High-Risk Non-Muscle Invasive Bladder Cancer Systemic Aging Associated with a Higher Risk of Early-Onset Solid Cancers MOST POPULAR Qué debo saber sobre la mastectomía con cierre plano después de... January 17, 2024 Measurable Residual Disease Adapted Consolidation Strategy After Quadruplet Induction Therapy for... July 8, 2025 Themes in Improving Supportive Care for People With Cancer: 2022 MASCC... September 1, 2022 Postneoadjuvant Trastuzumab Deruxtecan Results in Higher Likelihood of iDFS Among Patients... December 12, 2025 Load more HOT NEWS Many Patients with NSCLC Show Targetable Alterations in the PI3K Pathway “Chameleon-Like” Breast Cancer Cells Disguised as Neurons Can Lead to Brain... Speaking a thousand words – how a cancer image collection is... EMA Recommends Extension of Therapeutic Indications for Tisagenlecleucel
